Nuvation Bio Inc. Class A Common Stock vs Smurfit WestRock plc Ordinary Shares — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while Smurfit WestRock plc Ordinary Shares trades at $41.51 (market cap $21.66B). The key difference: Smurfit WestRock plc Ordinary Shares is far larger — about 12.7× Nuvation Bio Inc. Class A Common Stock's market cap, and Smurfit WestRock plc Ordinary Shares pays a 4.38% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Smurfit WestRock plc Ordinary Shares for 0 Days on average.
| NUVB | SW | |
|---|---|---|
Market Cap | $1.71B | $21.66B |
Volume | 5,448,712 | 3,627,328 |
Sector | Health | Consumer Cyclical |
52-Week High | $9.54 | $51.84 |
52-Week Low | $3.41 | $32.79 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.30B | $35.14B |
Dividend Yield | — | 4.38% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →Smurfit WestRock plc is an Ireland-headquartered packaging company that manufactures corrugated containers and consumer packaging from containerboard and paperboard, operating mills, converting plants, and recycling facilities across more than 40 countries.
Read more on SW →